Home Healthcare Biotechnology Intravenous Immunoglobulin Market

Intravenous Immunoglobulin Market Size, Share & Trends Analysis Report By Application (Hypogammaglobulinemia, CIDP, Immunodeficiency Diseases, Congenital AIDS, Chronic Lymphocytic Leukemia, Myasthenia Gravis, Multifocal Motor Neuropathy, ITP, Kawasaki Disease, Guillain-Barre Syndrome), By Distribution Channel (Hospital Pharmacy, Specialty Pharmacy) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Mitiksha Koul | Format: | Report Code: SR2187DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Intravenous Immunoglobulin Market Size Analysis
    1. Introduction
    2. Intravenous Immunoglobulin Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Hypogammaglobulinemia
      2. CIDP
      3. Immunodeficiency Diseases
      4. Congenital AIDS
      5. Chronic Lymphocytic Leukemia
      6. Myasthenia Gravis
      7. Multifocal Motor Neuropathy
      8. ITP
      9. Kawasaki Disease
      10. Guillain-Barre Syndrome
    3. Intravenous Immunoglobulin Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacy
      2. Specialty Pharmacy
  7. North America Intravenous Immunoglobulin Market Size Analysis
    1. Introduction
    2. Intravenous Immunoglobulin Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Hypogammaglobulinemia
      2. CIDP
      3. Immunodeficiency Diseases
      4. Congenital AIDS
      5. Chronic Lymphocytic Leukemia
      6. Myasthenia Gravis
      7. Multifocal Motor Neuropathy
      8. ITP
      9. Kawasaki Disease
      10. Guillain-Barre Syndrome
    3. Intravenous Immunoglobulin Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacy
      2. Specialty Pharmacy
    4. U.S.
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Specialty Pharmacy
    5. Canada
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Specialty Pharmacy
  8. Europe Intravenous Immunoglobulin Market Size Analysis
    1. Introduction
    2. Intravenous Immunoglobulin Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Hypogammaglobulinemia
      2. CIDP
      3. Immunodeficiency Diseases
      4. Congenital AIDS
      5. Chronic Lymphocytic Leukemia
      6. Myasthenia Gravis
      7. Multifocal Motor Neuropathy
      8. ITP
      9. Kawasaki Disease
      10. Guillain-Barre Syndrome
    3. Intravenous Immunoglobulin Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacy
      2. Specialty Pharmacy
    4. U.K.
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Specialty Pharmacy
    5. Germany
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Specialty Pharmacy
    6. France
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Specialty Pharmacy
    7. Spain
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Specialty Pharmacy
    8. Italy
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Specialty Pharmacy
    9. Russia
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Specialty Pharmacy
    10. Nordic
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Specialty Pharmacy
    11. Benelux
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Specialty Pharmacy
    12. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Specialty Pharmacy
  9. APAC Intravenous Immunoglobulin Market Size Analysis
    1. Introduction
    2. Intravenous Immunoglobulin Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Hypogammaglobulinemia
      2. CIDP
      3. Immunodeficiency Diseases
      4. Congenital AIDS
      5. Chronic Lymphocytic Leukemia
      6. Myasthenia Gravis
      7. Multifocal Motor Neuropathy
      8. ITP
      9. Kawasaki Disease
      10. Guillain-Barre Syndrome
    3. Intravenous Immunoglobulin Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacy
      2. Specialty Pharmacy
    4. China
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Specialty Pharmacy
    5. Korea
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Specialty Pharmacy
    6. Japan
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Specialty Pharmacy
    7. India
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Specialty Pharmacy
    8. Australia
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Specialty Pharmacy
    9. Taiwan
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Specialty Pharmacy
    10. South East Asia
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Specialty Pharmacy
    11. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Specialty Pharmacy
  10. Middle East and Africa Intravenous Immunoglobulin Market Size Analysis
    1. Introduction
    2. Intravenous Immunoglobulin Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Hypogammaglobulinemia
      2. CIDP
      3. Immunodeficiency Diseases
      4. Congenital AIDS
      5. Chronic Lymphocytic Leukemia
      6. Myasthenia Gravis
      7. Multifocal Motor Neuropathy
      8. ITP
      9. Kawasaki Disease
      10. Guillain-Barre Syndrome
    3. Intravenous Immunoglobulin Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacy
      2. Specialty Pharmacy
    4. UAE
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Specialty Pharmacy
    5. Turkey
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Specialty Pharmacy
    6. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Specialty Pharmacy
    7. South Africa
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Specialty Pharmacy
    8. Egypt
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Specialty Pharmacy
    9. Nigeria
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Specialty Pharmacy
    10. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Specialty Pharmacy
  11. LATAM Intravenous Immunoglobulin Market Size Analysis
    1. Introduction
    2. Intravenous Immunoglobulin Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Hypogammaglobulinemia
      2. CIDP
      3. Immunodeficiency Diseases
      4. Congenital AIDS
      5. Chronic Lymphocytic Leukemia
      6. Myasthenia Gravis
      7. Multifocal Motor Neuropathy
      8. ITP
      9. Kawasaki Disease
      10. Guillain-Barre Syndrome
    3. Intravenous Immunoglobulin Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacy
      2. Specialty Pharmacy
    4. Brazil
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Specialty Pharmacy
    5. Mexico
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Specialty Pharmacy
    6. Argentina
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Specialty Pharmacy
    7. Chile
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Specialty Pharmacy
    8. Colombia
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Specialty Pharmacy
    9. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Hypogammaglobulinemia
        2. CIDP
        3. Immunodeficiency Diseases
        4. Congenital AIDS
        5. Chronic Lymphocytic Leukemia
        6. Myasthenia Gravis
        7. Multifocal Motor Neuropathy
        8. ITP
        9. Kawasaki Disease
        10. Guillain-Barre Syndrome
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Specialty Pharmacy
  12. Competitive Landscape
    1. Intravenous Immunoglobulin Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Baxalta Incorporated
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Biotest AG
    3. China Biologic Products Inc.
    4. CSL Behring LLC
    5. Grifols S.A.
    6. Kedrion S.p.A.
    7. LFB Biomedicaments S.A.
    8. Octapharma AG
    9. Sanquin Plasma Products B.V.
    10. Bharat Serums and Vaccines Limited
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.